Steen Lisby Selected Research

zalutumumab

6/2014	An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck.
4/2011	Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steen Lisby Research Topics

Disease

5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2017 - 11/2011
4	Multiple Myeloma 10/2016 - 09/2015
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2017 - 07/2013
3	Neutropenia 10/2016 - 05/2015
3	Infections 10/2015 - 04/2011
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2013 - 04/2012
2	Disease Progression 01/2017 - 10/2016
2	Neoplasms (Cancer) 10/2016 - 04/2012
2	Squamous Cell Carcinoma of Head and Neck 06/2014 - 04/2011
2	Exanthema (Rash) 06/2014 - 04/2011
2	Pneumonia (Pneumonitis) 06/2014 - 04/2011
2	Contact Dermatitis (Eczema, Contact) 01/2004 - 09/2003
1	Lymphadenopathy 01/2017
1	Thrombocytopenia (Thrombopenia) 10/2016
1	Anemia 10/2016
1	Residual Neoplasm 10/2016
1	Fatigue 04/2016
1	Body Weight (Weight, Body) 09/2015
1	Relapsing-Remitting Multiple Sclerosis 02/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2013
1	Deglutition Disorders (Dysphagia) 04/2011
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 06/2007
1	Mycosis Fungoides 06/2007
1	Skin Diseases (Skin Disease) 02/2007
1	Necrosis 01/2004
1	Hypersensitivity (Allergy) 01/2004
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2004
1	Dermatitis 01/2004
1	Allergic Contact Dermatitis 06/2003

Drug/Important Bio-Agent (IBA)

14	ofatumumab FDA Link 02/2017 - 11/2011
7	Monoclonal AntibodiesIBA 10/2016 - 11/2011
5	fludarabineIBA 01/2017 - 11/2011
4	Rituximab (Mabthera)FDA Link 02/2017 - 11/2011
4	Dexamethasone (Maxidex)FDA LinkGeneric 02/2017 - 07/2013
4	daratumumabIBA 10/2016 - 09/2015
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 05/2012
3	PlatinumIBA 06/2014 - 04/2011
3	NickelIBA 01/2004 - 06/2003
2	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2017 - 07/2013
2	Cisplatin (Platino)FDA LinkGeneric 02/2017 - 07/2013
2	Lenalidomide (CC 5013)FDA Link 10/2016 - 10/2016
2	zalutumumabIBA 06/2014 - 04/2011
1	Thymidine KinaseIBA 01/2017
1	Complement C2 (Complement Component 2)IBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 10/2016
1	Proteasome InhibitorsIBA 04/2016
1	Immunomodulating AgentsIBA 04/2016
1	Chlorambucil (Leukeran)FDA Link 05/2015
1	Carboplatin (JM8)FDA LinkGeneric 07/2013
1	IceIBA 07/2013
1	Etoposide (VP 16)FDA LinkGeneric 07/2013
1	Ifosfamide FDA LinkGeneric 07/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2012
1	Vincristine (Oncovin)FDA LinkGeneric 05/2012
1	Prednisone (Sone)FDA LinkGeneric 05/2012
1	Alemtuzumab (Campath)FDA Link 11/2011
1	EpitopesIBA 11/2011
1	Methotrexate (Mexate)FDA LinkGeneric 04/2011
1	zanolimumabIBA 06/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2007
1	NF-kappa B (NF-kB)IBA 02/2007
1	6-sulfo sialyl Lewis XIBA 01/2004
1	InterleukinsIBA 01/2004
1	Interferon-gamma (Interferon, gamma)IBA 01/2004
1	Interleukin-4 (Interleukin 4)IBA 01/2004
1	Interleukin-5 (Interleukin 5)IBA 01/2004
1	Interleukin-6 (Interleukin 6)IBA 01/2004
1	CytokinesIBA 01/2004
1	Interleukin-10 (Interleukin 10)IBA 01/2004
1	Infliximab (Remicade)FDA Link 01/2004
1	AlloysIBA 06/2003
1	IonsIBA 06/2003

Therapy/Procedure

7	Therapeutics 10/2016 - 02/2007
3	Drug Therapy (Chemotherapy) 07/2013 - 04/2011
2	Stem Cell Transplantation 02/2017 - 11/2013
1	Salvage Therapy 02/2017
1	Retreatment 07/2015
1	Transplantation 11/2013